FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

9524511000001102: Agalsidase beta 35mg powder for solution for injection vials 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
31081901000001113 Agalsidase beta 35mg powder for solution for injection vials 1 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
52436801000001119 Agalsidase beta 35mg powder for solution for infusion vials 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Agalsidase beta 35mg powder for solution for injection vials 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Agalsidase beta 35mg powder for solution for injection vials 1 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Agalsidase beta 35mg powder for solution for injection vials 1 vial Is pack of Product containing precisely agalsidase beta 35 milligram/1 vial powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Agalsidase beta 35mg powder for solution for injection vials 1 vial Has active ingredient Beta-galactosidase false Inferred relationship Existential restriction modifier
Agalsidase beta 35mg powder for solution for injection vials 1 vial Has active ingredient Alpha-galactosidase false Inferred relationship Existential restriction modifier
Agalsidase beta 35mg powder for solution for injection vials 1 vial Has active ingredient Biological agent false Inferred relationship Existential restriction modifier
Agalsidase beta 35mg powder for solution for injection vials 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Agalsidase beta 35mg powder for solution for injection vials 1 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Agalsidase beta 35mg powder for solution for injection vials 1 vial Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Agalsidase beta 35mg powder for solution for injection vials 1 vial Has VMP Product containing precisely agalsidase beta 35 milligram/1 vial powder for conventional release solution for injection true Inferred relationship Existential restriction modifier
Agalsidase beta 35mg powder for solution for injection vials 1 vial Has specific active ingredient Agalsidase beta false Inferred relationship Existential restriction modifier
Agalsidase beta 35mg powder for solution for injection vials 1 vial Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Agalsidase beta 35mg powder for solution for injection vials 1 vial Has specific active ingredient Agalsidase beta true Inferred relationship Existential restriction modifier
Agalsidase beta 35mg powder for solution for injection vials 1 vial Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Fabrazyme 35mg powder for concentrate for solution for infusion vials (Sanofi Genzyme) 1 vial Is a True Agalsidase beta 35mg powder for solution for injection vials 1 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start